glp-1 for depression does glp 1 help agonist The Impact of Receptor Agonists ( GLP-1 RAs) on Mental Health: A Systematic Review Exploring the Side Effects of – GLP-1 Deprescribing Strategies for Chronic

SURMOUNT-4 The fourth study of the program, SURMOUNT-4, was designed to evaluate the efficacy of tirzepatide in weight loss maintenance in adult patients with a BMI 30 or 27 with an associated complication, but no T2D

Arthrospira platensis as future food: a review on functional ingredients, bioactivities and application in the food industry

Medication should not be offered as the sole treatment for binge eating disorder

We designed a study that applied the rigor of randomized controlled trials the gold standard in medicine to real-world data

Clinical trial results discussed in this article - STEP 1 (14.9% average body weight loss with semaglutide), SURMOUNT-1 (20.9% average body weight loss with tirzepatide), and SELECT (20% reduced risk of major cardiovascular events with FDA-approved Wegovy in a specific patient population) - relate to studied active ingredients and specific FDA-approved formulations in controlled trial populations and should not be interpreted as guaranteed outcomes for any individual patient or compounded formulation